October 1, 2013Translational OncologyOpen Access

Exposure to ACEI/ARB and β-Blockers Is Associated with Improved Survival and Decreased Tumor Progression and Hospitalizations in Patients with Advanced Colon Cancer

View Full Paper

Ask AI

Bookmark

Authors

DEDiana R. EngineerMichael E. DeBakey VA Medical Center BBBasil O. BurneyMichael E. DeBakey VA Medical Center THTeresa G. HayesBaylor College of Medicine

Discussion

Member takes

Implication

ACEI/ARB + β-blocker exposure was associated with improved survival in advanced colorectal cancer; leaves open whether randomized trials will confirm benefit.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Engineer et al. (2013) studied this question.

synapsesocial.com/papers/6a7dd2b1e5d85d18548c9dc3 https://doi.org/10.1593/tlo.13346

View Full Paper

Ask AI

Bookmark

Implication

ACEI/ARB + β-blocker exposure was associated with improved survival in advanced colorectal cancer; leaves open whether randomized trials will confirm benefit.

Exposure to ACEI/ARB and β-Blockers Is Associated with Improved Survival and Decreased Tumor Progression and Hospitalizations in Patients with Advanced Colon Cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Exposure to ACEI/ARB and β-Blockers Is Associated with Improved Survival and Decreased Tumor Progression and Hospitalizations in Patients with Advanced Colon Cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider